Galvanize Therapeutics, Inc.
Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation
HealthQuest Capital leads financing to support Aliya commercial expansion, clinical evidence generation, pipeline advancement, and development of…
